# Forms FDA 3542a and FDA 3542: Questions and Answers - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/forms-fda-3542a-and-fda-3542-questions-and-answers/1c3fd999-6eee-4b72-a157-e6a1d24cd719

> FDA guidance document: Forms FDA 3542a and FDA 3542: Questions and Answers. Issue date: June 15, 2026. Get complete insights and analysis.

---

## Details

- Title: Forms FDA 3542a and FDA 3542: Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-06-15
- Last Changed: 2026-06-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2026-D-2698">FDA-2026-D-2698</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.keypedia.com/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs](https://www.keypedia.com/guidances/guidance-document/content-and-format-of-composition-statement-and-corresponding-statement-of-ingredients-in-labeling-in-ndas-and-andas/a430f093-c9f8-4001-aef8-771d98ffdbf0)
- [Data Integrity for In Vivo Bioavailability and Bioequivalence Studies](https://www.keypedia.com/guidances/guidance-document/data-integrity-for-in-vivo-bioavailability-and-bioequivalence-studies/04d979b3-3f1d-4515-b9c1-f1a8fb7fb19b)